Scaling Veterinary Distribution Across East Africa: A Blueprint for Success

Why do so many veterinary products that work brilliantly elsewhere fail to reach the farmers and animals who need them most in East Africa?

It is not because the products are wrong. It is not because the farmers do not want them. It is because the journey from a factory floor in Europe or Asia to a smallholder farmer in rural Tanzania is a logistical, regulatory, and commercial obstacle course. And most manufacturers are not equipped to run it.

East Africa's livestock sector is a giant. We are talking about 107.2 million cattle, 178.8 million goats and sheep, and 1.3 million camels. That is not just a statistic it is a massive, growing market for veterinary pharmaceuticals, vaccines, and animal health products. The Middle East and Africa veterinary pharmaceuticals market alone is forecast to reach USD 469.2 million by 2031.

But here is the thing: demand alone does not equal sales. The real challenge is distribution. And for manufacturers serious about the East African Community (EAC), solving the distribution puzzle is not just a nice‑to‑have it is the critical path to commercial success.

Let us explore the opportunity, the challenges, and a practical framework for building a scalable, resilient veterinary supply chain across East Africa.

The Opportunity: A Region Ready for Growth

The EAC is not just a collection of countries. It is a dynamic, transforming region. Urbanisation is rising. Incomes are growing. And people are demanding more meat, milk, and eggs. This is fuelling a shift from subsistence farming to more commercial production and commercial farmers need effective, high‑quality animal health solutions.

The regulatory environment is also evolving to make market access easier. The EAC's Mutual Recognition Procedure (MRP) for veterinary medicines is a game‑changer. It allows manufacturers to apply for marketing authorisation simultaneously in multiple EAC Partner States. That means less time, less cost, and less paperwork. And the scope keeps expanding as of 2024, the MRP now includes ectoparasiticides, aquatic animal medicines, and nutritional supplements.

So, the opportunity is clear: a region with a vast and growing livestock population, a regulatory framework designed to enable market access, and clear demand for quality products.

But opportunity does not equal execution.

The Distribution Challenge: Why the Gap Persists

So, why do so many products fail to scale? The answer lies in the supply chain. The distribution of veterinary medicines in East Africa is a mix of formal and informal pathways. And while this might sound flexible, it creates significant risks for manufacturers trying to build a reliable, brand‑building presence.

Let us break it down.

Fragmented and Informal Channels: The route to market is often long and complex. In Kenya, for example, secondary wholesalers account for 60% of antibiotic distribution from importers to farmers. Add to that unauthorised middlemen and online platforms selling directly to retailers, and you have a landscape that is hard to control.

Infrastructure and Logistical Bottlenecks: Moving physical products is a major challenge. The region faces significant logistical hurdles, including limited cold chain capacity which is critical for vaccines and biologics. Poor roads, inadequate warehousing, and unreliable power supply in many areas add to the cost and complexity.

Regulatory and Policy Gaps: Despite the MRP's progress, implementation challenges persist. Enforcement is often hampered by financial and human resource constraints. This creates an uneven playing field where compliant manufacturers can be undercut by those operating outside the formal system.

These challenges are not insurmountable, but they require a deliberate, strategic approach. You cannot simply ship products to the region and hope for the best. Success requires a partner who understands the local terrain and has the infrastructure and expertise to navigate it.

A Blueprint for Success: Building a Scalable Supply Chain

Scaling veterinary distribution across East Africa requires a framework built on partnership, infrastructure, and a deep understanding of local market dynamics. Here is the blueprint.

1. Master the Regulatory Pathway with a Local Expert

The first step is not distribution. It is registration. The EAC Mutual Recognition Procedure is a powerful tool, but it is not a simple, turnkey solution. It requires a comprehensive registration dossier, compliance with Good Manufacturing Practice (GMP) guidelines, and a clear understanding of the requirements of both the Reference Country and the Concerned Countries.

Working with a local partner who has experience navigating this process is non‑negotiable. This partner can act as your local agent, manage the dossier submission, and ensure compliance with all regulatory requirements. They can also provide crucial intelligence on the national regulatory authorities in each Partner State, helping to anticipate and avoid potential bottlenecks.

2. Build the Infrastructure for Last‑Mile Delivery

Once your product is registered, it must reach the end user. This requires a robust distribution network. And we are not talking about a simple importer‑wholesaler‑retailer model. We are talking about building for control, consistency, and scale.

• Warehousing: This is the foundation. You need a partner with temperature‑controlled warehousing capabilities to protect the integrity of sensitive products like vaccines. Without this, product quality cannot be guaranteed.

• Logistics: The ability to move products efficiently from the port of entry to regional hubs and then to the point of sale is critical. A partner with established logistics networks and reliable transport providers can ensure that products arrive on time and in good condition.

• Last‑Mile Reach: The real value lies in reaching the end customer. This requires an understanding of the local retail landscape, which includes veterinary pharmacies, agrovet stores, and direct sales to large commercial farms. A strong local partner will have an established network and the ability to manage these diverse channels.

3. Prioritise Partnerships Over Transactions

Perhaps the most critical element of the blueprint is the nature of the relationship. A transactional importer‑exporter relationship is not enough to build a sustainable business in East Africa. You need a partner who is as invested in your long‑term success as you are. That means a partner who can offer more than just logistics:

• Market Intelligence: Real‑time feedback on market trends, competitor activity, and customer needs.

• Government Engagement: Established relationships with ministries of agriculture, veterinary authorities, and other key stakeholders who can advocate for your interests.

• Brand Building: A partner who treats your products with the same care and attention as their own brand, investing in marketing and customer education to build a strong market presence.

Why Simba Ustawi?

This is where Simba Ustawi comes in. We are not a typical distributor. We are a strategic execution and partnership firm with deep on‑ground expertise in Tanzania and a proven track record of navigating the regulatory and logistical hurdles that hold so many manufacturers back.

As the exclusive national distributor for BelAgroGen, we have already walked the path from market research to registration to active distribution. We know what it takes to succeed.

We do not just move products. We build market presence. We offer:

• End‑to‑end TMDA and TVLA registration management. We navigate the regulators so you do not have to.

• Temperature‑controlled warehousing and logistics. Your products stay safe from port to farm.

• A growing distribution network reaching Tanzania's key livestock regions.

• Government engagement with the Ministry of Livestock, the Tanzania Veterinary Laboratory Agency, and veterinary associations.

We are not just your distributor. We are your local partner.

Ready to Scale Across East Africa?

The opportunity is massive. The demand is real. But the path to commercial success requires more than a great product it requires a partner who understands the terrain.

If you are a veterinary pharmaceutical manufacturer looking to enter or expand in the EAC, let us talk.

👉 Partner With Us